Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03215238 · ClinicalTrials.gov registry record
Intraoperative Pleth Variability Index (PVI) Variability
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 10
- Enrollment target
NCT03215238: Clinical Trial study, sponsored by University of California, San Francisco.
NCT03215238 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03215238 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Pleth Variability Index (PVI) is a variable that is derived from photoplethysmography (PPG) signal. It is used as a surrogate for intravascular volume status intraoperatively. PVI can have significant amount of baseline variability which appears to oscillate at a very low frequency (5-10 minute cycles). This study aims to investigate the origin of these baseline oscillations.
Primary Outcome
PVI variability will be compare to raw infrared photoplethysmography signal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2018-11-30 |
Why NCT03215238 stopped before completion
NCT03215238 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03215238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03215238 about?
NCT03215238 is a clinical study titled "Intraoperative Pleth Variability Index (PVI) Variability". Pleth Variability Index (PVI) is a variable that is derived from photoplethysmography (PPG) signal. It is used as a surrogate for intravascular volume status intraoperatively. PVI can have significant amount of baseline variability which appears to oscillate at a very low frequency (5-10 minute cycl...
What is the current status of trial NCT03215238?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2017-10-01. Estimated completion is 2018-11-30.
Who is sponsoring clinical trial NCT03215238?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI